Ashish Life Science Competitors and Similar CompaniesClear all

Autolus's competitors and similar companies include Longeveron.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Longeveron
Longeveron
Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.
Founding Date
Founding Date
2014
Founding Date
2014
Type
Type
Public
Type
Public
Tags
Locations
Locations
London, GB HQ
London, GB
Locations
Miami, US HQ
Employees
Employees
647
Employees
259% increase
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
31.4 m

Financial

Revenue (est.)
Revenue (est.)
$75.4m (FY, 2025)
Revenue (est.)
$1.2m (FY, 2025)
Cost of goods
Cost of goods
$86.6m (FY, 2025)
Cost of goods
$396k (FY, 2025)
Gross profit
Gross profit
($10.7m) (FY, 2025)
Gross profit
$803k (FY, 2025)
Net income
Net income
($287.5m) (FY, 2025)
Net income
($22.7m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 281.7m
Total funding raised
$ 9m
For sources of this data, please see the company profile

View Company Profiles

Longeveron
HQ
Miami, US
Employees
25↑ 9% increase

Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.

View company